These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31484738)

  • 1. Broad and Effective Protection against Staphylococcus aureus Is Elicited by a Multivalent Vaccine Formulated with Novel Antigens.
    Deng J; Wang X; Zhang BZ; Gao P; Lin Q; Kao RY; Gustafsson K; Yuen KY; Huang JD
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31484738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection.
    Yang HJ; Zhang JY; Wei C; Yang LY; Zuo QF; Zhuang Y; Feng YJ; Srinivas S; Zeng H; Zou QM
    PLoS One; 2016; 11(2):e0149638. PubMed ID: 26895191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: Immunogenicity and protectivity.
    Haghighat S; Siadat SD; Rezayat Sorkhabadi SM; Akhavan Sepahi A; Sadat SM; Yazdi MH; Mahdavi M
    Microb Pathog; 2017 Jul; 108():32-39. PubMed ID: 28457901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model.
    Kuklin NA; Clark DJ; Secore S; Cook J; Cope LD; McNeely T; Noble L; Brown MJ; Zorman JK; Wang XM; Pancari G; Fan H; Isett K; Burgess B; Bryan J; Brownlow M; George H; Meinz M; Liddell ME; Kelly R; Schultz L; Montgomery D; Onishi J; Losada M; Martin M; Ebert T; Tan CY; Schofield TL; Nagy E; Meineke A; Joyce JG; Kurtz MB; Caulfield MJ; Jansen KU; McClements W; Anderson AS
    Infect Immun; 2006 Apr; 74(4):2215-23. PubMed ID: 16552052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
    Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus.
    Bagnoli F; Fontana MR; Soldaini E; Mishra RP; Fiaschi L; Cartocci E; Nardi-Dei V; Ruggiero P; Nosari S; De Falco MG; Lofano G; Marchi S; Galletti B; Mariotti P; Bacconi M; Torre A; Maccari S; Scarselli M; Rinaudo CD; Inoshima N; Savino S; Mori E; Rossi-Paccani S; Baudner B; Pallaoro M; Swennen E; Petracca R; Brettoni C; Liberatori S; Norais N; Monaci E; Bubeck Wardenburg J; Schneewind O; O'Hagan DT; Valiante NM; Bensi G; Bertholet S; De Gregorio E; Rappuoli R; Grandi G
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3680-5. PubMed ID: 25775551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Vaccines for
    Dupont CD; Scully IL; Zimnisky RM; Monian B; Rossitto CP; O'Connell EB; Jansen KU; Anderson AS; Love JC
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135219
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
    Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
    Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protective effect of a novel multi-antigen-chimeric vaccine against Streptococcus and Staphylococcus aureus infection in mice.
    Yu L; Fan Z; Ma J; Tong C; Song B; Zhu Z; Cui Y
    J Med Microbiol; 2014 Dec; 63(Pt 12):1732-1740. PubMed ID: 25288644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
    Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD
    Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome-wide antigen discovery of novel protective vaccine candidates against Staphylococcus aureus infection.
    Rasmussen KJ; Mattsson AH; Pilely K; Asferg CA; Ciofu O; Vitved L; Koch C; Kemp M
    Vaccine; 2016 Aug; 34(38):4602-4609. PubMed ID: 27496278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.
    Luna BM; Nielsen TB; Cheng B; Pantapalangkoor P; Yan J; Boyle-Vavra S; Bruhn KW; Montgomery C; Spellberg B; Daum R
    PLoS One; 2019; 14(6):e0217439. PubMed ID: 31181086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Staphylococcal Antigen-F (r-ScaF), a novel vaccine candidate against methicillin resistant Staphylococcus aureus infection: Potency and efficacy studies.
    Majelan PA; Mahdavi M; Yazdi MH; Salimi E; Pourmand MR
    Microb Pathog; 2019 Feb; 127():159-165. PubMed ID: 30521844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of using a combination of staphylococcal superantigen-like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureus.
    Chan JYH; Clow F; Pearson V; Langley RJ; Fraser JD; Radcliff FJ
    Immunol Cell Biol; 2024; 102(5):365-380. PubMed ID: 38572664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective humoral and CD4
    Yu W; Yao D; Yu S; Wang X; Li X; Wang M; Liu S; Feng Z; Chen X; Li W; Wang L; Liu W; Ma J; Yu L; Tong C; Song B; Cui Y
    Sci Rep; 2018 Feb; 8(1):3580. PubMed ID: 29483570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
    PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of Staphylococcus aureus from
    Harro JM; Achermann Y; Freiberg JA; Allison DL; Brao KJ; Marinos DP; Sanjari S; Leid JG; Shirtliff ME
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31712267
    [No Abstract]   [Full Text] [Related]  

  • 19. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.
    Moscoso M; García P; Cabral MP; Rumbo C; Bou G
    Virulence; 2018 Jan; 9(1):604-620. PubMed ID: 29297750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.